HIGHFDA DRUG

Amneal TRAMADOL HYDROCHLORIDE 50 mg Recall 29,542 Bottles Over Impurity (2026)

Amneal Pharmaceuticals is recalling 29,542 bottles of TRAMADOL HYDROCHLORIDE tablets distributed nationwide in the United States. The recall cites a failed impurity specification for N-nitroso-desmethyl-tramadol (NDSRI) at the 24‑month stability interval. Consumers and healthcare providers should stop using the product immediately and contact Amneal for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
March 19, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
March 19, 2026
Hazard Level
HIGH
Brands
TRAMADOL HYDROCHLORIDE, Amneal Pharmaceuticals NY LLC
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
TRAMADOL HYDROCHLORIDE, Amneal Pharmaceuticals NY LLC
Product type
Tramadol Hydrochloride Tablets 50 mg
Model numbers
AM230987, AR232387, Exp. Date 05/2026, Exp. Date 12/2026, 60219-2348-5
UPC codes
60219-2348, 60219-2348-4, 60219-2348-1, 60219-2348-5, 60219-2348-7
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    March 19, 2026

  2. Reported by FDA DRUG

    April 8, 2026

  3. RecallRadar source check

    April 15, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amneal Pharmaceuticals, LLC or your healthcare provider for guidance

About This Product

Tramadol hydrochloride tablets are prescription analgesics used to treat moderate to moderately severe pain. They require a doctor’s prescription and are dispensed by pharmacies. This recall involves a large batch distributed nationwide.

Why This Is Dangerous

The impurity NDSRI can pose health risks if ingested. The issue was detected during long-term stability testing at controlled storage conditions.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Consumers exposed to the impurity could experience adverse effects. The recall presents an urgent safety action for patients currently taking the affected product.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 60219-2348-5 on the package.
  2. Check Lot AM230987 and Exp dates 05/2026 or 12/2026.
  3. Look for AR232387 as applicable.
  4. Confirm distributor is Amneal Pharmaceuticals LLC, Glasgow, KY.

Where to find product info

FDA recall page and the Amneal recall notice through the FDA enforcement database.

What timeline to expect

Refund or replacement timelines are typically 4-6 weeks once the distributor processes the recall.

If the manufacturer is unresponsive

  • Document all correspondence with the supplier
  • File a complaint with FDA MedWatch if the company is slow to respond
  • Consult your pharmacist or doctor for guidance on safe alternatives.

How to prevent similar issues

  • Follow recall notices for prescription medications
  • Verify drug recalls before filling Rx refills
  • Ask clinicians and pharmacists to confirm product lot numbers
  • Check NDSRI-related safety alerts for opioids

Documentation advice

Keep packaging, lot numbers, expiry dates, receipts, and all recall communications for records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Bottle count: 500 per bottle. Quantity recalled: 29,542 bottles. NDC: 60219-2348-5. Lot numbers: AM230987. Expiration dates: 05/2026 and 12/2026. Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India. Distributed by: Amneal Pharmaceuticals LLC, Glasgow, KY 42141. Sold Rx only. Distribution: Nationwide in the USA.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 29,542 bottles recalled nationwide
  • NDSRI impurity out of specification at 24-month stability
  • Manufactured in India; Distributed by Amneal LLC in Kentucky

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANT
Injury Types
POISONINGOTHER

Product Classification

Product Details

Model Numbers
AM230987
AR232387
Exp. Date 05/2026
Exp. Date 12/2026
60219-2348-5
UPC Codes
60219-2348
60219-2348-4
60219-2348-1
+2 more
Affected States
ALL
Report Date
April 8, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more